Invalidity dossier

US 12264358

Added 5/12/2026, 6:00:43 AM

IndustryMedical (M)

Got a demand letter citing US 12264358?

Paste the full letter into the analyzer. We extract every asserted patent (this one and any others), characterize the asserter, flag validity vulnerabilities, and draft a sample response letter your attorney can adapt.

Analyze a letter →

Generic sample response letter (PDF)

Generates a draft reply letter to a generic infringement claim citing this patent, using the analysis below. For a response tailored to a specific letter you received, use the demand letter analyzer instead. Sample only — not legal advice. Do not send without review by a licensed patent attorney.

Download sample PDF →

Watchlist

Get alerted when this patent moves.

Email-only, free, anonymous. We'll notify you when US 12264358 gets a new lawsuit, a new PTAB proceeding, or a new dossier section. One-click unsubscribe from any alert.

Active provider: Google · gemini-2.5-pro

Patent summary

Title, assignee, inventors, filing/issue dates, abstract, and a plain-language overview of the claims.

✓ Generated

Summary of U.S. Patent 12,264,358

A search of the United States Patent and Trademark Office (USPTO) database and the Court of Appeals for the Federal Circuit (CAFC) 2026 dockets for patent number 12264358 did not yield any direct results. The following summary is based on the authoritative text provided.

Title: Method of selectively sequencing amplicons in a biological sample

Assignee: Harvard University (originally assigned to President and Fellows of Harvard College)

Inventors:

  • George M. Church
  • Jehyuk Lee
  • Richard C. Terry
  • Evan R. Daugharthy

Filing Date: May 2, 2024

Issue Date: April 1, 2025

Abstract:
Methods of selectively sequencing amplicons in a biological sample are provided.

Plain-Language Overview of Independent Claims:
The provided text for US Patent 12,264,358 does not include the specific claims of the patent. Therefore, a plain-language overview of the independent claims cannot be provided.

The patent generally describes methods for creating a three-dimensional matrix of nucleic acids (DNA or RNA) and then amplifying, detecting, and sequencing these nucleic acids directly within that matrix. A key aspect is the ability to perform these steps in situ, meaning within their original context, such as inside a cell or tissue sample. This preserves the spatial orientation of the nucleic acids, providing information about their location. The invention allows for the nucleic acids to be fixed in place by being covalently bound to a porous, optically transparent matrix material, such as a polyacrylamide gel. This stable structure allows for repeated cycles of sequencing and imaging, effectively turning the biological sample into a stable information storage medium that can be read multiple times.

Generated 5/12/2026, 6:45:48 AM